Erasca Q2 net loss widens on higher R&D costs
Brief: Erasca Q2 Basic EPS USD -0.14
U.S. STOCKS ON THE MOVE-Bank of America, Analog Devices, Newmont
U.S. STOCKS ON THE MOVE-Bank of America, Analog Devices, Newmont
Cancer biotech Erasca rallies after upsized $550 mln share sale, analyst PT hikes
U.S. STOCKS ON THE MOVE-Lulu's Fashion Lounge Holdings, Goldman Sachs, Analog Devices
U.S. STOCKS ON THE MOVE-Lulu's Fashion Lounge Holdings, Wells Fargo, Bank of America
Cancer biotech Erasca down premarket after $550 mln share sale
Brief: Erasca Announces Pricing Of Upsized Public Offering Of Common Stock
Brief: Erasca Announces Updated Preliminary Phase 1 Data, Registration-Enabling Plans For Potentially Best-In-Class Pan-Ras Molecular Glue Eras-0015 In Kras-Mutant Solid Tumors
Cancer biotech Erasca falls after announcing $500 mln stock offering
Erasca Q1 net loss widens on higher R&D costs
Brief: Erasca Q1 Basic EPS USD -0.6
U.S. STOCKS ON THE MOVE-Barrick Mining, Lumentum, Tesla
U.S. STOCKS ON THE MOVE-Moderna, Beazer Homes, Lumentum
U.S. STOCKS ON THE MOVE-Liquidia, Target Hospitality, oil companies
U.S. STOCKS ON THE MOVE-Philip Morris, Circle, Erasca
Erasca rises after Merck cancer drug combo pact
U.S. STOCKS ON THE MOVE-AxoGen, energy companies, Corning